Tango Therapeutics (TNGX) Profit After Tax (2020 - 2025)
Historic Profit After Tax for Tango Therapeutics (TNGX) over the last 6 years, with Q3 2025 value amounting to $15.9 million.
- Tango Therapeutics' Profit After Tax rose 15445.88% to $15.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$100.5 million, marking a year-over-year increase of 1854.21%. This contributed to the annual value of -$130.3 million for FY2024, which is 2806.85% down from last year.
- According to the latest figures from Q3 2025, Tango Therapeutics' Profit After Tax is $15.9 million, which was up 15445.88% from -$38.9 million recorded in Q2 2025.
- Over the past 5 years, Tango Therapeutics' Profit After Tax peaked at $15.9 million during Q3 2025, and registered a low of -$39.9 million during Q1 2025.
- In the last 5 years, Tango Therapeutics' Profit After Tax had a median value of -$25.6 million in 2024 and averaged -$24.3 million.
- Its Profit After Tax has fluctuated over the past 5 years, first plummeted by 95180677.97% in 2021, then skyrocketed by 15445.88% in 2025.
- Quarter analysis of 5 years shows Tango Therapeutics' Profit After Tax stood at -$22.0 million in 2021, then plummeted by 31.82% to -$29.1 million in 2022, then decreased by 5.86% to -$30.8 million in 2023, then decreased by 22.45% to -$37.7 million in 2024, then skyrocketed by 142.17% to $15.9 million in 2025.
- Its last three reported values are $15.9 million in Q3 2025, -$38.9 million for Q2 2025, and -$39.9 million during Q1 2025.